city_hall

Official websites use .boston.gov

A .boston.gov website belongs to an official government organization in the City of Boston.

lock

Secure .gov websites use HTTPS

A lock or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Global Industry and Partnerships

Boston’s cannabis industry exists within a broader, growing, and global industry and cannabis ecosystem of policy, business, and innovation. Explore legal and emerging frameworks from jurisdictions around the world, and opportunities for knowledge exchange and cross-sector collaboration.

Europe

Austria

Medical cannabis permitted for pharmaceutical use; recreational use illegal. Small possession may be diverted to health authorities.

Belgium

Medical cannabis allowed in limited cases; CBD products regulated under national health authority.

Croatia

Medical cannabis permitted through prescription and pharmacy distribution.

Cyprus

Medical cannabis legal with licensed cultivation and pharmaceutical production.

Czech Republic

Medical cannabis legal; government advancing legislation toward a regulated adult-use market.

Denmark

Medical cannabis pilot program allows regulated cultivation, production, and prescriptions.

Estonia

Medical cannabis permitted through prescription under strict pharmaceutical regulation.

Finland

Medicinal cannabis requires special authorization from The Finnish Medicines Agency (Fimea), and it is only approved for specific, treatment-resistant conditions.

France

National medical cannabis pilot program testing regulated patient access.

Georgia

Personal cannabis use and possession legalized; commercial activity remains illegal.

Germany

Cannabis legalized for personal use, cultivation, and nonprofit social clubs; medical cannabis available under regulated framework.

Greece

Medical cannabis legal with licensed cultivation and pharmaceutical production.

Ireland

Medical Cannabis Access Programme permits limited patient access under specialist supervision.

Italy

Medical cannabis legal and produced through government-authorized cultivation for pharmaceutical use.

Lithuania

Medical cannabis legal through prescription medicines.

Luxembourg

Medical cannabis available via prescription; limited personal use and home cultivation permitted; no commercial retail market.

Malta

First EU country to legalize adult use; nonprofit cannabis associations regulated by national authority.

Netherlands

Cannabis retail allowed in licensed coffeeshops; medical cannabis regulated; government piloting legal cultivation.

North Macedonia

Medical cannabis program with licensed cultivation and production.

Norway

Medical cannabis permitted through prescription in limited circumstances.

Poland

Medical cannabis legal and available through prescription pharmacies.

Portugal

Medical cannabis legal with licensed cultivation and pharmaceutical distribution.

San Marino

Medical cannabis permitted through pharmacy distribution.

Slovenia

Medical cannabis permitted through pharmaceutical products

Spain

Cannabis social clubs operate regionally and private consumption is decriminalized; national medical cannabis framework under development.

Switzerland

Medical cannabis legal; cities running regulated adult-use pilot programs for research. Cannabis is decriminalized for private personal use and cultivation, while public consumption and commercial sale remain illegal.

Ukraine

Medical cannabis legalized in 2024 for treatment of certain conditions.

United Kingdom

Medical cannabis legal since 2018 but tightly restricted; access available through specialist prescriptions.

Connect with us

Boston is committed to building meaningful connections across the global cannabis landscape. Interested in partnering, sharing information about your industry, or learning more? Connect with our team to explore opportunities for collaboration and global engagement.

Back to top